Dianthus Therapeutics, Inc. (DNTH)

NASDAQ: DNTH · Real-Time Price · USD

21.75

+0.30 (1.40%)

Apr 29, 2025, 4:00 PM EDT - Market closed

Dianthus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 29, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	699	645	154	-	-
Market Cap Growth	318.69%	318.69%	-	-	-
Enterprise Value	343	364	-35	-	-
Last Close Price	21.75	21.80	10.40	-	-
PS Ratio	116.21	103.48	54.53	-	-
PB Ratio	1.92	1.83	0.91	-	-
P/TBV Ratio	1.98	1.83	0.91	-	-
EV/Sales Ratio	55.05	58.45	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01	-
Asset Turnover	0.02	0.02	0.02	0.14	-
Quick Ratio	14.96	14.96	18.09	9.86	1.70
Current Ratio	15.22	15.22	18.43	9.97	1.75
Return on Equity (ROE)	-32.60%	-32.60%	-35.92%	-73.25%	-
Return on Assets (ROA)	-23.01%	-23.01%	-22.94%	-40.12%	-
Return on Capital (ROIC)	-24.33%	-24.33%	-24.69%	-47.27%	-
Earnings Yield	-12.16%	-13.17%	-28.26%	-	-
FCF Yield	-11.20%	-12.13%	-23.99%	-	-
Buyback Yield / Dilution	-546.44%	-546.44%	-489.48%	78.17%	-

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q